201. New Vaccines/New Challenges
Saturday, October 29, 2016: 8:30 AM-10:00 AM
Room: 278-282

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify the potential benefits of and challenges to developing Norovirus vaccines
  • identify progress towards developing vaccines to prevent Dengue
  • identify characteristics of existing and new vaccines for Herpes Zoster

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Global ID, Investigative ID, Pediatric ID

Moderators:  Walter A. Orenstein, MD, FIDSA, FPIDS, Emory University and Andrew Pavia, MD, FIDSA, FSHEA, FPIDS, University of Utah School of Medicine

8:30 AM
Prospects for Vaccines to Prevent Dengue
Scott Halstead, MD, FIDSA

8:55 AM
9:25 AM
9:30 AM
Vaccines to Prevent Zoster
Myron Levin, MD, FIDSA

9:55 AM

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-286-L01-P


W. A. Orenstein, None

A. Pavia, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.